|
000
| 01305nam##2200265za#4500 |
|---|
| 001 | 9.571770 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624182905 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406|2011||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-19402-8 |
|---|
| 022 | |a1701-5413 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aFA1-2011/2-4E-PDF |
|---|
| 110 | 1 |aCanada. |bOffice of the Auditor General. |
|---|
| 245 | 10|aReport of the Auditor General of Canada to the House of Commons. Chapter 4, : |h[electronic resource]|bregulating pharmaceutical drugs - Health Canada |
|---|
| 260 | |aOttawa - Ontario : |bOffice of the Auditor General of Canada |
|---|
| 300 | |a46p.|bfig., tables |
|---|
| 490 | 1 |aReport of the Auditor General of Canada to the House of Commons|x1701-5413|vFall 2011 |
|---|
| 590 | |a12-02|b2012-01-13 |
|---|
| 775 | 08|tRapport du vérificateur général du Canada à la Chambre des communes. Chapitre 4, : |w(CaOODSP)9.602195 |
|---|
| 776 | 0#|tReport of the Auditor General of Canada to the House of Commons. Chapter 4, : |w(CaOODSP)9.620226 |
|---|
| 830 | #0|aReport of the Auditor General of Canada to the House of Commons,|x1701-5413|vFall 2011|w(CaOODSP)9.506219 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s348 KB|uhttps://publications.gc.ca/collections/collection_2012/bvg-oag/FA1-2011-2-4-eng.pdf|yFall 2011 |
|---|